Oxford Nanopore Technologies /ONT

-1.11%
-
1D1W1MYTD1YMAX

About Oxford Nanopore Technologies

Oxford Nanopore Technologies plc is engaged in the generation of molecular sensing technology based on nanopores. The Company has developed a deoxyribonucleic (DNA)/ ribonucleic acid (RNA) sequencing technology. The Company’s segments include Life Science Research Tools, which offers products and services for research use, and COVID Testing, which provides products for SAR-Cov-2 testing. Its sequencing technology offers real-time analysis, in fully scalable formats from pocket to population scale, that can analyze native DNA or RNA and sequence any length of fragment to achieve short to ultra-long read lengths. Its products include MinION, GridION, PromethION, Flongle and others. MinION is a real-time device for DNA and RNA sequencing. GridION is a benchtop device designed to run and analyze up to five MinION or Flongle Flow Cells. Flongle is an adapter for MinION or GridION that enables direct, real-time DNA sequencing, or cDNA sequencing on smaller, single-use flow cells.

Ticker

ONT

Sector

Healthcare

Trading on

LSE

Industry

Medical Equipment & Supplies

CEO

Gurdial Sanghera

Employees

1,238

Headquarters

Oxford, United Kingdom

ONT Metrics

BasicAdvanced
£812.66M
Market cap
-
P/E ratio
-£0.19
EPS
-
Beta
-
Dividend rate
£812.66M
£2.79
£0.92
1.29M
5.013
3.875
5.798
6.47
-19.3%
-23.11%
-21.93%
4.79
1.261
1.33
-14.57%
-67.61%
14.22%

What the Analysts think about ONT

Analyst Ratings

Majority rating from 10 analysts.
Buy

Price Targets

Average projection from 9 analysts.
132.26% upside
High £3.50
Low £1.15
£0.93
Current price
£2.16
Average price target

ONT Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-100.95% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
£83.6M
-2.79%
Net income
£-84.4M
20.57%
Profit margin
-100.95%
24.03%

ONT Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 2.14%
QuarterlyAnnual
Q4 21
Q2 22
Q4 22
Q2 23
Actual
-£0.07
-£0.00
-£0.14
-£0.07
Expected
-£0.00
-£0.00
-£0.06
-£0.07
Surprise
8,133.33%
-20%
129.18%
-2.14%
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Oxford Nanopore Technologies stock?

Oxford Nanopore Technologies (ONT) has a market cap of £797.61M as of April 21, 2024.

What is the P/E ratio for Oxford Nanopore Technologies stock?

The price to earnings (P/E) ratio for Oxford Nanopore Technologies (ONT) stock is 0 as of April 21, 2024.

Does Oxford Nanopore Technologies stock pay dividends?

No, Oxford Nanopore Technologies (ONT) stock does not pay dividends to its shareholders as of April 21, 2024.

When is the next Oxford Nanopore Technologies dividend payment date?

Oxford Nanopore Technologies (ONT) stock does not pay dividends to its shareholders.

What is the beta indicator for Oxford Nanopore Technologies ?

Oxford Nanopore Technologies (ONT) does not currently have a Beta indicator.

What is the Oxford Nanopore Technologies stock price target?

The target price for Oxford Nanopore Technologies (ONT) stock is £2.16, which is 132.26% above the current price of £0.93. This is an average based on projections from 9 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Oxford Nanopore Technologies  stock

Buy or sell Oxford Nanopore Technologies stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing